Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 546 of 6351
-
New combo aims to save bladders in cancer fight
Disease control Not yet recruitingThis is a phase II clinical study to evaluate the efficacy of RC48-ADC combined with toripalimab bladder-sparing therapy. The RC48-ADC dose in this study is 2.0 mg/kg Q2W and toripalimab is 3 mg/kg Q2W. This study plans to enroll 59 participants. The participants will start dru…
Phase 2 • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New surgery aims to stop lymphedema before it starts
Prevention Recruiting nowImmediate lymphatic reconstruction (ILR) is a novel surgical approach performed at the time of initial lymph node dissection with the goal of preventing lymphedema.(Chang et al. 2020) It involves the identification of lymphatic channels that are transected after lymph node dissec…
Sponsor: University of Chicago • Aim: Prevention
Last updated Jun 27, 2026 08:04 UTC
-
Heart failure and AF: which procedure works best?
Disease control Not yet recruitingAtrial Fibrillation (AF) and Heart Failure (HF) are colliding global cardiovascular epidemics, individually impairing quality of life and cardiac performance, as well as increasing the risk of hospitalisation and mortality. When AF and HF co-exist, disease progression accelerates…
Phase 4 • Sponsor: University of British Columbia • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Engineered immune cells take on tough leukemia in early trial
Disease control Recruiting nowThis study aims to evaluate the safety and efficacy of LILRA6-directed chimeric antigen receptor T cells (LILRA6 CAR-T cells) in patients with refractory or relapsed acute myeloid leukemia(AML).
Phase 1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
AI breakthrough: predicting breast Cancer's next move
Knowledge-focused Recruiting nowBreast cancer is one of the most common malignancies in women worldwide, and distant metastasis is the main cause of poor prognosis and death. This project aims to construct a precision prediction system based on multi-omics (digital pathology, immunohistochemistry, proteomics, g…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Poop pills take on superbugs in new clinical trial
Disease control Not yet recruitingThe aim of the study is to see whether fecal microbiota transplantation is effective to decolonize multidrug-resistant organisms.
Sponsor: Kyungpook National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Radioactive seeds aim to boost Chemo's punch against breast cancer
Disease control Not yet recruitingThis study is an open-label, controlled, multicenter phase III clinical trial designed to evaluate whether the use of iodine-125 radioactive seed markers can improve treatment response for patients with early or locally advanced breast cancer undergoing neoadjuvant therapy. Neoa…
Phase 3 • Sponsor: Pengfei Qiu • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New mRNA vaccine targets brain tumors in early trial
Disease control Recruiting nowThis clinical trial is designed to evaluate the safety and efficacy of a universal mRNA vaccine targeting a panel of glioma-associated mutations in patients with recurrent or progressive high-grade glioma. The primary objectives are to address the following key questions: 1) Is …
Phase 1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New hope for teens with rare obesity: weekly shot shows promise
Disease control Recruiting nowThis observational study aims to assess the effect of once-weekly s.c. semaglutide 2.4 mg as an adjunct to a calorie-reduced diet and increased physical activity on weight loss, change in hunger, body composition, depression, and quality of life after 68 weeks of treatment in ado…
Sponsor: Prof. Dr. Martin Wabitsch • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Could your own immune cells fight advanced cancer? new trial aims to find out
Disease control Not yet recruitingThe autologous immune cell induction technology used in this project involves transforming peripheral blood mononuclear cells (PBMC) into autologous DC cells, NK cells, CIK cells and other immune cells through cytokine induction, and then re-administering them to the patients. Th…
Phase 1/2 • Sponsor: Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Experimental immune cell combo targets Drug-Resistant lung cancer
Disease control Recruiting nowThis prospective Phase II study aims to evaluate the preliminary efficacy and safety of WAST cells combined with docetaxel as second-line therapy in patients with advanced NSCLC resistant to PD-1 inhibitors.
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New stroke treatment could help patients with medium-artery blockages
Disease control Recruiting nowRESCUE-M2O trial is a prospective, open label, blinded endpoint (PROBE), two-arm, randomized, controlled, post-market study to assess the efficacy and safety of endovascular therapy for acute ischemic stroke with occlusion of the M2 segment of the middle cerebral artery.
Sponsor: Hyogo Medical University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Triple threat: radiation, chemo, and immunotherapy join forces against advanced rectal cancer
Disease control Recruiting nowTo enhance the treatment efficacy of rectal cancer liver metastasis through a multidisciplinary approach of radiotherapy, immunotherapy, and chemotherapy, and to provide a new direction for the combination treatment strategy.
Phase 2 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New hope for Hard-to-Treat colorectal cancer? drug combo trial launches
Disease control Recruiting nowThis study aims to evaluate the safety, tolerability, and efficacy of pirfenidone and PD-1 monoclonal antibody combined with or without hypofractionated radiotherapy in the treatment of advanced refractory pMMR/MSS colorectal cancer patients.
Phase 2 • Sponsor: Tao Zhang • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could a smart device at home tame Post-Surgery pain and prevent chronic pain?
Disease control Recruiting nowAcute postoperative pain (APOP) is a major public health problem, affecting nearly 10 million patients in France each year. Effective analgesic therapy in the first postoperative week is a key factor in reducing early postoperative morbidity and mortality. Poorly controlled APOP …
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Heart failure hope for kids: diabetes drug tested as new therapy
Disease control Recruiting nowthe study to investigate the efficacy of empagiflozin in pediatric heart failure
Phase 2 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Herbal granules may offer new hope for aging kidneys
Disease control Recruiting nowThis prospective real-world study will evaluate the clinical benefits of Niaoduqing Granules in older adults with impaired kidney function. Approximately 300 participants aged over 60 years with stage 3 to 5 chronic kidney disease who are not receiving dialysis will be enrolled a…
Phase 4 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can Mindfulness-Based therapy break the grip of internet addiction?
Disease control CompletedInternet addiction, a growing epidemic among young adults, significantly impairs mental health, emotional regulation, and overall well-being. The pervasive overuse of digital technologies-particularly smartphones, social media, and the internet-has led to rising rates of anxiety,…
Sponsor: National University of Modern Languages • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a classroom program heal trauma in teens?
Symptom relief Recruiting nowThis study will evaluate whether a school-based counseling program, Cognitive Behavioral Intervention for Trauma in Schools (CBITS), helps reduce trauma-related symptoms and improve psychological functioning in adolescents in Pakistan who have experienced traumatic events. Studen…
Sponsor: National University of Modern Languages • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Shock waves vs. scope: a Head-to-Head battle for kidney stone relief
Disease control CompletedUpper ureteric stones can be treated using extracorporeal shock wave lithotripsy or ureteroscopy. Extracorporeal shock wave lithotripsy breaks the stone using shock waves delivered from outside the body, whereas ureteroscopy involves passing a small instrument through the urinary…
Sponsor: Hanzla Arshad • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC